NCT06982677Recruiting
Improving Outcomes in Early Menopause After Cancer
Improving Outcomes for Women Experiencing Premature or Early Menopause After Cancer: Development and Pilot Testing of a Novel Intervention
Source: ClinicalTrials.gov · Last updated 14 May 2026
Brief summary (registry, in English)
The goal of this study is to create and test a new program led by nurse navigators to help women who experience early menopause after cancer. The program includes personalized menopause education, decision support, and skills to manage menopause symptoms. The main questions it aims to answer are: 1. Is the program easy to join, engaging, and well-received by participants? 2. Does the program group show greater improvements in knowledge, decision-making, confidence, and menopause symptom management compared to the control group? Participants will complete sessions of either the program being tested or an educational control program with a nurse navigator via video. Participants will also complete questionnaires when they start the study and again about 10 weeks later.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 117 (estimated)
- First submitted
- 5 May 2025
- Start date
- 20 Jan 2026
- Primary completion date
- May 2027
- Lead sponsor
- Duke University
- NCT number
- NCT06982677
What you commit to
- Study type: Interventional
- Planned participants: 117
- From 20 Jan 2026 to the primary completion date, May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- diagnosis of metastatic cancer;
- visual or hearing impairment that would interfere with participation in study;
- cognitive impairment or severe mental illness that would interfere with participation in study.
Who the study is looking for
- female (biological sex);
- 18 to 44 years old;
- completed cancer treatment (other than endocrine therapy) \>12 months prior to enrollment;
- have not had a period for more than 12 months (amenorrhea);
- able to speak and read English.
Age in the registry: 18 years to 44 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke Cancer Institute Coordinator of this site? Confirm its status | Durham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.